Role of HLA molecular mismatch in clinical practice
Authors:
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 83 (3) , 219-224
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 34 references indexed in Scilit:
- Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant RecipientsJournal of the American Society of Nephrology, 2015
- The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft SurvivalAmerican Journal of Transplantation, 2015
- Predicting Alloreactivity in TransplantationJournal of Immunology Research, 2014
- Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve OutcomesAmerican Journal of Transplantation, 2013
- Prognosis Research Strategy (PROGRESS) 3: Prognostic Model ResearchPLOS Medicine, 2013
- Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney TransplantAmerican Journal of Transplantation, 2012
- Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Predicting HLA Class I Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid PolymorphismsTransplantation, 2009
- HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DPHuman Immunology, 2007
- Significance of the Positive Crossmatch Test in Kidney TransplantationNew England Journal of Medicine, 1969